End to End Regulatory Services for Life Sciences

Medical Device.
Regulatory Done Right.

Regulatory affairs is a complex and ever-evolving discipline, and nowhere is that complexity more evident than in the medical device sector. The regulatory landscape for medical devices has undergone fundamental change in recent years — post Brexit UKCA requirements, the full transition to EU MDR and IVDR, new MHRA frameworks and an increasingly divergent dual market environment have created significant compliance challenges for device manufacturers operating across UK and European markets simultaneously. At BioReg Life Sciences we provide expert end to end regulatory support for medical device companies — from Class I diagnostics through to Class III implantable devices, combination products and in vitro diagnostics. Our senior team brings decades of hands on experience navigating MHRA, FDA, EU MDR and global device regulatory frameworks — giving medical device companies the strategic guidance, technical expertise and submission capability they need to achieve and maintain market approval with confidence. We work with device manufacturers from the earliest stages of regulatory planning — conducting gap analyses, building market entry strategies and defining the most efficient route to UKCA and CE marking — through to full technical documentation preparation, submission management and post approval lifecycle maintenance. For combination products and drug device combinations we provide integrated regulatory support across both the pharmaceutical and device elements of the submission — managing the complexity of dual regulatory frameworks through a single point of contact. Post Brexit, we also specialise in helping device manufacturers navigate the dual UKCA and CE marking requirements — managing both UK and EU compliance simultaneously so you can access both markets without duplication of effort or unnecessary cost. Whatever stage your device programme is at — BioReg Life Sciences has the expertise, the experience and the commitment to get your device to market and keep it there.

Regulatory Gap Analysis

Bringing a medical device to market requires navigating one of the most technically complex and rapidly evolving regulatory frameworks in the life sciences industry. Whether you are developing a Class I diagnostic tool or a Class III implantable device, understanding exactly where your technical documentation, clinical evidence and quality systems stand against current regulatory requirements is the essential first step — and in the post Brexit dual UK and EU landscape, getting this right has never been more important.

At BioReg Life Sciences our medical device gap analysis service gives you a comprehensive and honest assessment of your current regulatory position against MHRA, FDA and global device specific requirements. We evaluate your technical documentation, clinical evaluation reports, quality management systems and manufacturing compliance — identifying deficiencies, flagging risks and delivering a clear prioritised roadmap to get you submission and approval ready.

Whether you are preparing for your first MHRA registration, approaching a CE marking assessment or entering the US market for the first time, our gap analysis gives you the clarity to move forward with confidence.

Artwork and Labelling

Medical device labelling is one of the most heavily regulated and carefully scrutinised elements of the device approval process. Labels must comply with strict MHRA, FDA and global regulatory requirements covering device identification, intended purpose, warnings, instructions for use, storage conditions and unique device identification — UDI — requirements that are now mandatory across UK and EU markets.

At BioReg Life Sciences we provide expert artwork and labelling support for medical device companies — ensuring every label, carton, instructions for use document and promotional material meets the precise regulatory standards required for market access in your target geographies.

Our team manages the full device labelling process — from initial regulatory assessment and artwork preparation through to review, approval and submission ready formatting. We ensure your labelling is fully compliant with current MHRA, EU MDR and FDA requirements — including UDI implementation — and clearly communicates the critical safety and performance information that device regulators and healthcare professionals expect.

With BioReg Life Sciences managing your device labelling, nothing gets missed and nothing gets rejected.

Lifecycle Management

Regulatory approval for a medical device is not the end of the compliance journey — it is the beginning of an ongoing obligation that demands continuous expert attention. Post approval device programmes carry significant lifecycle requirements including variation management, post market surveillance reporting, periodic safety update reports, labelling updates and regular engagement with MHRA, notified bodies and other regulatory authorities.

At BioReg Life Sciences we provide comprehensive lifecycle management services specifically tailored to the demands of medical device programmes — ensuring your device remains fully compliant throughout its commercial life. From post approval variations and renewals through to PSUR submissions, labelling updates, UDI maintenance and regulatory authority correspondence, we manage every obligation with the same precision and dedication we bring to initial approvals.

Your complete regulatory dossier is securely hosted in our managed document system — giving you continuous access to your submission history, technical documentation and compliance records at all times. With BioReg Life Sciences managing your device lifecycle, your product stays compliant and your team stays focused on innovation.

Regulatory Strategy

The medical device regulatory landscape has changed fundamentally in recent years — post Brexit UKCA requirements, the transition to EU MDR and IVDR, new MHRA frameworks and an increasingly complex dual market environment have created significant strategic challenges for device manufacturers operating across UK and European markets.

At BioReg Life Sciences we provide expert regulatory strategy support for medical device companies — helping you define the most efficient and commercially intelligent route to market approval across your target geographies. We advise on device classification, conformity assessment route selection, market sequencing, notified body engagement strategy and the optimal approach for managing dual UKCA and CE marking requirements simultaneously.

Every device programme is unique. Our senior team works closely with you to build a regulatory strategy that reflects your device's classification, your target markets and your commercial timeline — giving you a clear and actionable roadmap from development through to approval and beyond. We ensure you make the right strategic decisions early — before they become costly ones later.

Regulatory Submissions and eCTD Publishing

For medical device companies requiring eCTD submissions — particularly those developing combination products, drug device combinations or devices requiring full dossier submissions to MHRA or FDA — the technical quality of your regulatory submission is everything. A single formatting error, validation failure or structural issue can delay your approval and set your programme back significantly.

At BioReg Life Sciences regulatory submissions and eCTD publishing is at the heart of what we do. With over 5,000 submissions completed and a 100% acceptance rate across pharmaceutical, biotech and device programmes, we bring unmatched precision and reliability to every dossier we compile, validate and submit. Using industry leading Freyr publishing software we ensure your complete submission is technically compliant with MHRA, FDA and all relevant global regulatory authority requirements.

From initial submission planning through to final authority confirmation, we manage every aspect of the submission process — coordinating all workstreams, managing timelines and ensuring your dossier reaches the right authority in the right format at the right time.

Lifecycle Management

Regulatory approval is not the finish line — it is the beginning of an ongoing compliance commitment. Post approval, your product must remain continuously compliant through variations, renewals, labelling updates, safety reporting and regular interactions with regulatory authorities. For many companies this is where the cracks start to appear.

At BioReg Life Sciences we manage your complete regulatory lifecycle so they never do. From post approval variations and PSUR submissions to authority query management and product renewals, we handle every obligation with the same precision we bring to initial submissions. Your full regulatory dossier is securely hosted in our managed document system, giving you continuous access to your submission history and compliance records at all times.

With BioReg Life Sciences managing your lifecycle, your product stays compliant, your team stays focused and your business keeps moving forward.

Lifecycle Management

With BioReg Life Sciences managing your lifecycle, your product stays compliant, your team stays focused and your business keeps moving forward.

Professional office consultation in action.png

Promotional Material Review & Submissions

Medical device promotional materials are subject to strict regulatory requirements — every claim made about a device's performance, safety and intended use must be accurate, evidence based and compliant with MHRA, FDA and relevant advertising standards.

In a regulatory environment where device claims are increasingly scrutinised, ensuring your promotional materials meet the required standard before they reach healthcare professionals or patients is not optional — it is essential.

At BioReg Life Sciences we provide expert promotional materials review and submission support for medical device companies — ensuring every promotional document, sales aid, patient communication and digital marketing material is accurate, compliant and fully aligned with your device's approved intended purpose and performance claims.

Our team reviews materials against current MHRA requirements, FDA promotional standards and relevant industry codes — identifying compliance issues, recommending corrections and managing formal submission processes where required. We ensure your promotional activities support your device's market access and reputation — never compromise it.

Regulatory Document Templates

Having the right regulatory document templates in place from the earliest stages of your medical device programme can save significant time, reduce errors and ensure your technical documentation meets regulatory expectations before a single submission is made. In the post Brexit environment — where UKCA and CE marking requirements increasingly diverge — working from the right frameworks from day one is not just efficient, it is essential for companies managing dual market compliance.

At BioReg Life Sciences we provide a comprehensive library of medical device specific regulatory document templates — covering the full range of documents required across your submission programme. From technical file templates and clinical evaluation report frameworks through to risk management plan templates, post market surveillance plan templates, UDI documentation templates and MHRA registration document templates — our library gives your team the regulatory scaffolding to build compliant, submission ready documents efficiently.

All templates are maintained and updated in line with current MHRA, EU MDR, IVDR and FDA requirements — ensuring you are always working to the latest standards.

Medical Writing Support

The technical documentation supporting a medical device regulatory submission must meet an exceptionally high standard of scientific accuracy, regulatory precision and structural compliance. Poorly written, incomplete or non-compliant technical documentation is one of the most common causes of notified body queries, MHRA rejections and FDA deficiency letters — costly setbacks that delay market access and drain resources at the most critical stage of development.

At BioReg Life Sciences we provide comprehensive document writing support across your medical device regulatory dossier — delivering accurately written, submission ready documents that meet the precise standards expected by MHRA, FDA, notified bodies and global regulatory authorities.

Our experienced team produces clinical evaluation reports, technical file documentation, instructions for use, risk management documentation, quality management system documentation and the full suite of administrative documents required for device submissions. For more complex scientific content we work with our trusted network of specialist medical and technical writers — ensuring your complete dossier is supported by the right expertise throughout.

ChatGPT Image Apr 1, 2026, 11_38_55 PM.png

UKCA & CE Marking Support

Post Brexit, medical device manufacturers selling in both the UK and European markets face a dual regulatory compliance challenge that has no precedent in the history of the industry. UKCA marking is now required for the Great Britain market while CE marking under EU MDR and IVDR remains mandatory for European market access — and the two frameworks, while broadly similar, are diverging in ways that create significant compliance complexity for manufacturers operating across both markets.

At BioReg Life Sciences we provide specialist UKCA and CE marking support — helping medical device manufacturers navigate the dual compliance requirements of the UK and EU regulatory frameworks simultaneously. We advise on conformity assessment routes, notified body and approved body engagement, technical documentation requirements and the most efficient strategy for achieving and maintaining both UKCA and CE marking with minimum duplication of effort and cost.

Whether you are a UK manufacturer seeking to maintain EU market access or a European manufacturer entering the UK market for the first time, BioReg Life Sciences provides the expert guidance you need to succeed in both markets.

Post Market Surveillance

Post market surveillance is one of the most critical and resource intensive ongoing regulatory obligations for medical device manufacturers — and one of the areas most commonly underprepared for at the point of approval. MHRA, EU MDR and FDA all require robust, systematic and continuously updated post market surveillance programmes that demonstrate your device continues to meet safety and performance requirements throughout its commercial life.

At BioReg Life Sciences we provide comprehensive post market surveillance support for medical device companies — helping you design, implement and maintain the surveillance systems and reporting processes that regulators expect. Our team supports the preparation of Post Market Surveillance Plans, Post Market Clinical Follow Up reports, Periodic Safety Update Reports for devices and Summary of Safety and Clinical Performance documents — ensuring your post market obligations are met accurately and on time.

We also support regulatory authority interactions arising from post market surveillance findings — managing queries, coordinating responses and ensuring your device maintains its market authorisation without interruption.

Why choose BioReg Life Sciences for your regulatory needs?

BioReg Life Sciences supports pharmaceutical, biotech and gene therapy companies with every stage of the regulatory journey — from early development through to post-authorisation and lifecycle management. Whatever your regulatory challenge, our senior consultants work with you to build a balanced, realistic and achievable strategy that aligns with your company's vision. We manage and publish your submissions, advise on complex regulatory requirements, and support your successful market launch and ongoing compliance.Talk to us for an open, no-obligation conversation about how we can help.

Medical Device. Regulatory Done Right.

Regulatory Gap Analysis

Why choose BioReg Life Sciences for your regulatory needs?

Medical Device.
Regulatory Done Right.